Targeted therapies in leukemia
1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
- Contribution to journal › Article
-
Mark
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes
- Contribution to journal › Article
- 2024
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
- Contribution to journal › Published meeting abstract
-
Mark
Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases
- Contribution to journal › Article
-
Mark
Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
- Contribution to journal › Article
-
Mark
Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells
- Contribution to journal › Article
-
Mark
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling
- Contribution to journal › Article
- 2023
-
Mark
Skin mesenchymal niches maintain and protect AML-initiating stem cells
- Contribution to journal › Article
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
- Contribution to journal › Article
-
Mark
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
